(HedgeCo.Net). In a notable strategic move, Brevan Howard Asset Management (a major macro hedge-fund firm) has committed US$200 million to invest in Catalio Capital Management’s healthcare stock fund. Reuters
Details:
- Catalio is a New York-based healthcare investment firm (~US$2.3 billion AUM) that returned 49 % net-of-fees since inception in 2023. Reuters
- The investment highlights a growing trend: hedge-fund firms investing into other funds (multi-manager or fund-of-fund style allocations) — in this case, an external fund rather than just internal strategies.
- It signals that large hedge-fund platforms are diversifying not only strategies but also investment vehicles and partnerships.
Why this matters: This move underscores changing business models in the hedge-fund industry — rather than solely internal alpha generation, large firms are actively allocating to external niche managers. This may open new paths for smaller or specialist firms seeking capital.
Watch for: Whether more hedge funds follow suit, what terms (fees, governance, transparency) apply in such investments, and how these partnerships impact overall performance and investor access.Today’s hedge fund headlines
